SCHEMBL16107285

SCHEMBL16107285

Oc1cc(Cl)c2c(c1)[C@@](O)(C(F)(F)F)c1ccccc1-2

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13434420 1.00 PDK2 (0.78) PDK2
SCHEMBL13128003 0.88 PDK2 (1.00) PDK2
SCHEMBL1712518 0.85 PDK2 (1.00) PDK2
SCHEMBL13128788 0.85 PDK2 (1.00) PDK2
SCHEMBL16064856 0.84 PDK2 (1.00) PDK2
SCHEMBL16769231 0.84 PDK2 (0.76) PDK2
SCHEMBL16139288 0.84 PDK2 (0.76) PDK2
SCHEMBL1712520 0.84 PDK2 (1.00) PDK2
SCHEMBL13128786 0.84 PDK2 (1.00) PDK2
SCHEMBL13434317 0.82 PDK2 (1.00) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3805205-A1 PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR Japan Tobacco Inc. (JP) 2021-04-14 — — EP disclosed
US-20200163937-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-05-28 — — US disclosed
US-20200163937-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-05-28 — — US disclosed
US-20180256547-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2018-09-13 — — US disclosed
EP-3348545-A1 PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR Japan Tobacco Inc. (JP) 2018-07-18 — — EP disclosed
EP-2975028-B1 PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR JAPAN TOBACCO INC (JP) 2018-02-21 — — EP disclosed
US-20160074364-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2016-03-17 — — US disclosed
US-20160074364-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2016-03-17 — — US disclosed
US-20160074364-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2016-03-17 — — US disclosed
EP-2975028-A1 PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR Japan Tobacco, Inc. (JP) 2016-01-20 — — EP disclosed
US-9040717-B2 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2015-05-26 — — US disclosed
US-9040717-B2 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2015-05-26 — — US disclosed
US-9040717-B2 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. (JP) 2015-05-26 — — US disclosed
US-20150025120-A1 PYRAZOLE-ALCOHOL COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2015-01-22 — — US disclosed
US-20150025120-A1 PYRAZOLE-ALCOHOL COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2015-01-22 — — US disclosed
US-20150025120-A1 PYRAZOLE-ALCOHOL COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2015-01-22 — — US disclosed
WO-2015002119-A1 PYRAZOLE-ALCOHOL COMPOUND AND PHARMACEUTICAL APPLICATION THEREFOR 日本たばこ産業株式会社 (JP) 2015-01-08 — — WO disclosed
US-20140296315-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2014-10-02 — — US disclosed
US-20140296315-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2014-10-02 — — US disclosed
US-20140296315-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2014-10-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296315-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF NAT1, CYP2C19, CYP3A5 PDK2 92/4885
US-20150025120-A1 PYRAZOLE-ALCOHOL COMPOUNDS AND PHARMACEUTICAL USE THEREOF ADH5, ADH1A, CYP3A43 PDK2 18/4885
US-20180256547-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF NAT1, CYP2C19, CYP3A5 PDK2 92/4885
US-20160074364-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF NAT1, CYP2C19, CYP3A5 PDK2 92/4885
US-20200163937-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF NAT1, CYP2C19, CYP3A5 PDK2 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback